Takeda San Diego
Takeda San Diego (TSD) is Takeda's global center for excellence in structure-based drug discovery. TSD integrates cutting-edge protein crystallography and drug discovery technologies to efficiently generate Investigational New Drug (IND) candidates for the treatment of metabolic diseases and cancer. Multiple drug candidates discovered at TSD are currently in clinical trials including SYR322, a potential treatment for type II diabetes.
Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited is Japan's largest pharmaceutical company, and is the world-leader in oral diabetes medicines.
Highlights
09/04/2007
Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
02/07/2005
Takeda To Acquire Syrrx
Career Opportunities
Takeda San Diego has more than 100 employees, and is expanding its world-class team of drug hunters, providing excellent opportunities for career development and job satisfaction in a beautiful environment.